A Nature Biomedical Engineering analysis says the FDA’s 2026 guidance on consumer wearables leaves major unresolved issues in how sensor-based wellness devices should be regulated.
The authors focus on 4 gaps—validation standards, safety risks, definitional coherence and healthcare integration—as wearables increasingly measure health-linked physiological signals.
That blurring of wellness and medical functions can place similar data under different regulatory regimes, raising questions about whether current rules adequately match device capabilities.
The paper frames the guidance as a policy inflection point for products such as rings, watches and other sensors that are moving closer to clinical use.